INmune Bio and QCi Combine Quantum Computing and AI to Study Drug Applications
Biopharma firm pairs with Quantum Computing Inc. for AI-assisted drug research

INmune Bio has partnered with Quantum Computing Inc. to employ quantum algorithms, artificial intelligence and data analysis in preclinical drug discovery. The initiative aims to uncover additional therapeutic uses for the biotech firm's experimental treatment, XPro.
Original source
This summary was written by the GPU Data Hub desk from reporting published by HPCwire on 14 Oct 2026, 18:38. Read the full article at the original publisher.
Read Original Source →